Industry News

Drugmaker: Simeprevir showed better safety profile than telaprevir in HCV patients

March 18, 2014
Simeprevir was safer than telaprevir among patients with hepatitis C virus, according to data presented by Medivir AB at the Conference of the Asian…
In the Journals

Liver disease persists in HIV/HCV coinfected patients despite ART

March 17, 2014
Patients coinfected with HIV and hepatitis C have higher rates of liver decompensation compared with patients with hepatitis C monoinfection, despite…
Meeting News Coverage

HCV care gaps in US identified by treatment cascade

March 11, 2014
A treatment cascade for hepatitis C patients in the United States identified gaps in care and pointed to a need for improvements in diagnosis…
In the Journals

Increased baby boomer HCV prevalence spurs focus on detection, treatment

March 9, 2014
Given the unusually high burden of hepatitis C virus infection affecting the baby boomer generation, it is essential to identify those with infection…
In the Journals

HCV prevalence, cost burden continue to rise

February 26, 2014
The hepatitis C virus has a profound negative impact on patients’ quality of life, both in its clinical manifestations and its overall…
In the Journals

HCV increased risk for dying prematurely

February 25, 2014
Adults with hepatitis C had an increased risk for dying and for dying prematurely compared with the general population, according to findings from a…
In the Journals

HCV under-documented on death certificates

February 21, 2014
Only 19% of people dying with hepatitis C virus had the disease listed on their death certificates, according to CDC researchers. “This…
Industry News

Walgreens expands HCV pharmacy services

February 19, 2014
Walgreens announced that the company is expanding access to its Connected Care hepatitis C program to more than 100 specialized pharmacies, designed…

Vitamin D levels failed to predict HCV treatment outcome

February 14, 2014
Vitamin D levels did not show any significant association with the outcome of antiviral therapy among a cohort infected with hepatitis C virus…
In the Journals

Current HCV therapies may not benefit older patients

February 12, 2014
A sustained virologic response to existing hepatitis C treatments — namely, pegylated interferon and ribavirin combined with a protease…